VLS Valneva SE

VALNEVA Declaration of shares and voting rights: January 31, 2026

VALNEVA Declaration of shares and voting rights: January 31, 2026

VALNEVA

Declaration of shares and voting rights

January 31, 2026

__________________________________________________________________________________________

Company name: VALNEVA

Registered office: Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 Lyon

Regulated market of Euronext Paris - Compartment B

Declaration date: February 6, 2026

Number of shares

composing the share capital of Valneva
Total number of voting rights including suspended voting rights*Description of the change Date on which this change was recognizedTotal number of voting rights excluding suspended voting rights**
 



173,877,420



ordinary shares with a par value of €0.15 each
189,607,235Double voting rights granted on 890 ordinary shares



 



Transfer into bearer form of 159,714 shares with double voting rights



 



Exercise of stock options resulting in the issuance of 337,675 new ordinary shares
Between January 8 & January 30, 2026



 



On January 9, 2026



 



Between January 12 & January 30, 2026
189,482,913

___________________________

* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

** Net (or exercisable at a General Meeting) voting rights.

Attachment



EN
06/02/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Valneva SE

 PRESS RELEASE

VALNEVA Declaration of shares and voting rights: January 31, 2026

VALNEVA Declaration of shares and voting rights: January 31, 2026 VALNEVA Declaration of shares and voting rights January 31, 2026__________________________________________________________________________________________ Company name: VALNEVARegistered office: Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 LyonRegulated market of Euronext Paris - Compartment B Declaration date: February 6, 2026 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the change Date on which this c...

 PRESS RELEASE

VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026

VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026 VALNEVA Déclaration d’actions et de droits de vote 31 janvier 2026__________________________________________________________________________________________ Dénomination sociale : VALNEVAAdresse du siège social : Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 Lyon Marché réglementé Euronext Paris - Compartiment B Date de la déclaration : 6 février 2026 Nombre d’actions composant le capital de ValnevaNombre total de droits de vote incluant les droits de vote suspendus*Origine de la variati...

Martial Descoutures
  • Martial Descoutures

Valneva : What is at stake for VLA15 in Lyme disease?

After particularly promising phase II results in Lyme disease, unveiled at end-2025, we see the stock offering an attractive risk/reward profile ahead of the phase III results for VLA15 expected in the coming weeks. In a high-potential segment with no competition, VLA15 boasts a unique position, now central to Valneva's development and valuation momentum. We maintain our Outperform rating, with an adjusted target price of € 8.1 vs € 7.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch